United Kingdom Orthobiologics Market Outlook to 2020

News provided by

Apr 28, 2014, 01:31 ET

LONDON, April 28, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

United Kingdom Orthobiologics Market Outlook to 2020

http://www.reportbuyer.com/pharma_healthcare/treatments/orthopaedic/united_kingdom_orthobiologics_market_outlook_2020.html

Summary

GlobalData's new report, "United Kingdom Orthobiologics Market Outlook to 2020", provides key market data on the United Kingdom Orthobiologics market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Bone Graft Substitutes, Viscosupplementation, Bone Allografts and Bone Growth Stimulators.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Orthobiologics market wherever available.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size for Orthobiologics market categories - Bone Graft Substitutes, Viscosupplementation, Bone Allografts and Bone Growth Stimulators.
- Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2005 to 2012 and forecast to 2020.
- 2012 company shares and distribution shares data for each of the market categories.
- Global corporate-level profiles of key companies operating within the United Kingdom Orthobiologics market.
- Key players covered include DePuy Companies, Sanofi, Medtronic, Inc., NuVasive, Inc., Biomet, Inc., Smith & Nephew Plc, Baxter International Inc., Wright Medical Group, Inc., Stryker Corporation and Alphatec Holdings, Inc.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Introduction 5
2.1 What Is This Report About? 5
2.2 Orthobiologics Market Segmentation 5
2.3 Definitions of Markets Covered in the Report 6
3 Orthobiologics Market, United Kingdom 7
3.1 Orthobiologics Market, United Kingdom, Revenue ($m), 2005-2012 7
3.2 Orthobiologics Market, United Kingdom, Revenue ($m), 2012-2020 9
3.2.1 Bone Graft Substitutes Market, United Kingdom, Revenue ($m), by Segment, 2005-2012 11
3.2.2 Bone Graft Substitutes Market, United Kingdom, Revenue ($m), by Segment, 2012-2020 13
3.3 Orthobiologics Market, United Kingdom, Volume (Units), 2005-2012 15
3.4 Orthobiologics Market, United Kingdom, Volume (Units), 2012-2020 17
3.4.1 Bone Graft Substitutes Market, United Kingdom, Volume (Units), by Segment, 2005-2012 19
3.4.2 Bone Graft Substitutes Market, United Kingdom, Volume (Units), by Segment, 2012-2020 21
3.5 Orthobiologics Market, United Kingdom, Average Price ($), 2005-2020 23
3.6 Orthobiologics Market, United Kingdom, Distribution Share by Revenue ($m), 2011-2012 25
3.7 Orthobiologics Market, United Kingdom, Company Share by Revenue ($m), 2011-2012 26
4 Overview of Key Companies in United Kingdom Orthobiologics Market 28
4.1 Medtronic, Inc. 28
4.1.1 Company Overview 28
4.2 DePuy Companies 28
4.2.1 Company Overview 28
4.3 Sanofi 28
4.3.1 Company Overview 28
4.4 DJO Finance LLC 29
4.4.1 Company Overview 29
4.5 Baxter International Inc. 29
4.5.1 Company Overview 29
4.6 Orthofix International N.V. 29
4.6.1 Company Overview 29
4.7 Wright Medical Group, Inc. 30
4.7.1 Company Overview 30
4.8 Biomet, Inc. 30
4.8.1 Company Overview 30
4.9 Smith & Nephew Plc 31
4.9.1 Company Overview 31
4.10 Globus Medical, Inc. 31
4.10.1 Company Overview 31
4.11 Anika Therapeutics, Inc. 31
4.11.1 Company Overview 31
4.12 NuVasive, Inc. 32
4.12.1 Company Overview 32
4.13 Alphatec Holdings, Inc. 32
4.13.1 Company Overview 32
4.14 Stryker Corporation 33
4.14.1 Company Overview 33
4.15 Seikagaku Corporation 33
4.15.1 Company Overview 33
5 Orthobiologics Market Pipeline Products 34
6 Financial Deals Landscape 36
6.1 Asset Transactions 36
6.1.1 Biomet Completes Acquisition Of Trauma Business Of Depuy Orthopaedics For US$280 Million 36
6.2 Partnerships 38
6.2.1 Artimplant Enters Into Co-Marketing Agreement With Tiller International Capital 38
6.2.2 aap Implantate Enters Into Licensing Agreement With Medical Technology Company For Injectable Bone Matrix 39
7 Recent Developments 40
7.1 Government and Public Interest 40
7.1.1 Sep 10, 2013: Bone Biologics to Webcast, Live, at RetailInvestorConferences.com on September 12th 40
7.2 Product News 40
7.2.1 Mar 19, 2013: Ranier Technology Gets US Patent For Graduated Modulus Technology 40
8 Appendix 41
8.1 Research Methodology 42
8.1.1 Coverage 42
8.1.2 Secondary Research 42
8.1.3 Primary Research 43
8.1.4 Market Modeling and Forecasting 44
8.1.5 Company Share Analysis 47
8.1.6 Distribution Share Analysis 48
8.2 Expert Panel 49
8.3 GlobalData Consulting 49
8.4 Contact Us 49
8.5 Disclaimer 49

List of Tables

Table 1: Orthobiologics Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2005-2012 8
Table 2: Orthobiologics Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2012-2020 10
Table 3: Bone Graft Substitutes Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2005-2012 12
Table 4: Bone Graft Substitutes Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2012-2020 14
Table 5: Orthobiologics Market, United Kingdom, Volume (Units), Historic, 2005-2012 16
Table 6: Orthobiologics Market, United Kingdom, Volume (Units), Forecast, 2012-2020 18
Table 7: Bone Graft Substitutes Market, United Kingdom, Volume (Units), Historic, 2005-2012 20
Table 8: Bone Graft Substitutes Market, United Kingdom, Volume (Units), Forecast, 2012-2020 22
Table 9: Orthobiologics Market, United Kingdom, Average Price ($), Historic, 2005-2012 23
Table 10: Orthobiologics Market, United Kingdom, Average Price ($), Forecast, 2012-2020 24
Table 11: Orthobiologics Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2011-2012 25
Table 12: Orthobiologics Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2011-2012 27
Table 13: Orthobiologics Market Pipeline Products 34
Table 14: Biomet Completes Acquisition Of Trauma Business Of Depuy Orthopaedics For US$280 Million 36
Table 15: Artimplant Enters Into Co-Marketing Agreement With Tiller International Capital 38
Table 16: aap Implantate Enters Into Licensing Agreement With Medical Technology Company For Injectable Bone Matrix 39
Table 17: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country 44

List of Figures

Figure 1: Orthobiologics Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2005-2012 7
Figure 2: Orthobiologics Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2012-2020 9
Figure 3: Bone Graft Substitutes Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2005-2012 11
Figure 4: Bone Graft Substitutes Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2012-2020 13
Figure 5: Orthobiologics Market, United Kingdom, Volume (Units), Historic, 2005-2012 15
Figure 6: Orthobiologics Market, United Kingdom, Volume (Units), Forecast, 2012-2020 17
Figure 7: Bone Graft Substitutes Market, United Kingdom, Volume (Units), Historic, 2005-2012 19
Figure 8: Bone Graft Substitutes Market, United Kingdom, Volume (Units), Forecast, 2012-2020 21
Figure 9: Orthobiologics Market, United Kingdom, Company Share (%), 2012 26
Figure 10: GlobalData Epidemiology-Based Forecasting Model 46
Figure 11: GlobalData Capital Equipment-Based Forecasting Model 47
Figure 12: Primary Interviews by Participant Type (%) 48